Atlas Trials

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer(SPARKLE)

Clinical trial NCT06767007 · RECRUITING

Trial details

NCT number
NCT06767007
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Unresectable Locally Recurrent Rectal Cancer
Start date
2025-01-06
Primary completion
2026-11-30
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.